Doctor profile · Federal record
Dr. MICHAEL PACK, DO
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · KALAMAZOO, MI
- NPI 1508822966
- Accepts Medicare
- MIPS 83.8 / 100 · 2023
- 24 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
601 JOHN ST, SUITE 100
KALAMAZOO, MI 490075341
(269) 373-1592
fax (269) 373-6270
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- November 27, 2023
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- Michigan #5101017554
- Medicaid
- MI #1508822966
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1508822966. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,378
Distinct HCPCS
10
Medicare allowed
$128,725
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 417 | 346 | $87 | |
93010 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 360 | 279 | $8 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 241 | 238 | $66 | |
93296 |
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 183 | 88 | $21 | |
93294 |
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 182 | 88 | $29 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 127 | 109 | $14 | |
93018 |
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 120 | 119 | $13 | |
93280 |
Programming of dual lead pacemaker system | 111 | 71 | $76 | |
78452 |
Nuclear medicine studies of heart muscle at rest and with stress and spect | 75 | 75 | $73 | |
93298 |
Evaluation of cardiac rhythm monitor system, remote up to 30 days | 68 | 13 | $26 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 77. This provider delivers 31× the peer median.Open Payments
Industry payments received
All-time total
$13,172
Transactions
118
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Boston Scientific Corporation | 40 | $10,391.39 | |
| Abbott Laboratories | 11 | $1,818.83 | |
| Novartis Pharmaceuticals Corporation | 26 | $300.68 | |
| E.R. Squibb & Sons, L.L.C. | 20 | $235.35 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $76.34 | |
| Amgen Inc. | 4 | $61.09 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $52.27 | |
| PFIZER INC. | 3 | $51.48 | |
| Janssen Pharmaceuticals, Inc | 2 | $30.19 | |
| Alnylam Pharmaceuticals Inc. | 1 | $22.99 | |
| CARDIVA MEDICAL, INC. | 1 | $21.34 | |
| Kiniksa Pharmaceuticals International, plc | 1 | $21.04 | |
| Merck Sharp & Dohme LLC | 1 | $19.38 | |
| Lexicon Pharmaceuticals, Inc. | 1 | $18.28 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $18.08 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,397
Patients
1,217
Total drug cost
$1,395,965
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metoprolol Succinate | Generic | 968 | 291 | $20,662 |
| Eliquis (Apixaban) | Brand | 574 | 143 | $654,279 |
| Xarelto (Rivaroxaban) | Brand | 476 | 113 | $524,565 |
| Metoprolol Tartrate | Generic | 268 | 74 | $2,745 |
| Carvedilol | Generic | 265 | 67 | $4,096 |
| Flecainide Acetate | Generic | 253 | 64 | $17,288 |
| Lisinopril | Generic | 244 | 67 | $2,179 |
| Amlodipine Besylate | Generic | 216 | 56 | $2,129 |
| Atorvastatin Calcium | Generic | 216 | 64 | $4,925 |
| Amiodarone Hcl | Generic | 205 | 61 | $6,726 |